The effect of thymosine 1 alpha and lamivudine combination therapy in chronic hepatitis B patients [1]

Basit Öğe Kaydı
dc.contributor.authorDikici Bünyamin
dc.contributor.authorBoşnak Mehmet
dc.contributor.authorHaspolat K.
dc.date.accessioned2024-04-24T17:58:42Z
dc.date.available2024-04-24T17:58:42Z
dc.date.issued2002
dc.departmentDicle Üniversitesien_US
dc.description.abstract[No abstract available]en_US
dc.identifier.endpage702en_US
dc.identifier.issn0019-6061
dc.identifier.issue7en_US
dc.identifier.pmid12147907
dc.identifier.scopus2-s2.0-0036070541
dc.identifier.scopusqualityQ2
dc.identifier.startpage701en_US
dc.identifier.urihttps://hdl.handle.net/11468/24063
dc.identifier.volume39en_US
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoenen_US
dc.relation.ispartofIndian Pediatrics
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleThe effect of thymosine 1 alpha and lamivudine combination therapy in chronic hepatitis B patients [1]en_US
dc.titleThe effect of thymosine 1 alpha and lamivudine combination therapy in chronic hepatitis B patients [1]
dc.typeLetteren_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu